CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 806 JPY -2.66% Market Closed
Market Cap: 16B JPY
Have any thoughts about
CellSource Co Ltd?
Write Note

Operating Margin
CellSource Co Ltd

12.7%
Current
30%
Average
3.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.7%
=
Operating Profit
566.4m
/
Revenue
4.4B

Operating Margin Across Competitors

Country JP
Market Cap 16B JPY
Operating Margin
13%
Country US
Market Cap 1.2T USD
Operating Margin
14%
Country US
Market Cap 202.3B USD
Operating Margin
17%
Country US
Market Cap 166.6B USD
Operating Margin
21%
Country KR
Market Cap 66.8T KRW
Operating Margin
31%
Country CH
Market Cap 38.4B CHF
Operating Margin
13%
Country US
Market Cap 38.8B USD
Operating Margin
24%
Country US
Market Cap 36.2B USD
Operating Margin
14%
Country US
Market Cap 27B USD
Operating Margin
28%
Country US
Market Cap 24B USD
Operating Margin
20%
Country CN
Market Cap 164.4B CNY
Operating Margin
27%
No Stocks Found

CellSource Co Ltd
Glance View

Market Cap
16B JPY
Industry
Life Sciences Tools & Services

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Intrinsic Value
947.13 JPY
Undervaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.7%
=
Operating Profit
566.4m
/
Revenue
4.4B
What is the Operating Margin of CellSource Co Ltd?

Based on CellSource Co Ltd's most recent financial statements, the company has Operating Margin of 12.7%.